Spg20-/- mice reveal multimodal functions for Troyer syndrome protein spartin in lipid droplet maintenance, cytokinesis and BMP signaling

Human Molecular Genetics

Volumn 21, Issue 16, 2012, Pages 3604-3618

  Renvoisé, Benoît ^a   Stadler, Julia ^a   Singh, Rajat ^a   Bakowska, Joanna C ^b   Blackstone, Craig ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN RECEPTOR; ESCRT PROTEIN; FAT DROPLET; IST1 PROTEIN; PERILIPIN; PROTEIN; SMAD1 PROTEIN; SMAD5 PROTEIN; SPARTIN PROTEIN; SPG20 PROTEIN; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BONE GROWTH; BRAIN CELL; CARTILAGE CELL; COGNITIVE DEFECT; CONTROLLED STUDY; CYTOKINESIS; DISTAL AMYOTROPHY; EMBRYO; EMBRYONIC FIBROBLAST; EPIPHYSIS PLATE; FEMALE; FIBROBLAST; GAIT DISORDER; GENE DISRUPTION; HEREDITARY MOTOR SENSORY NEUROPATHY; HISTOPATHOLOGY; IN VIVO STUDY; LOSS OF FUNCTION MUTATION; MALE; MOUSE; MUSCLE ATROPHY; NERVE CELL CULTURE; NERVE FIBER GROWTH; NEUROPATHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SHORT STATURE; SIGNAL TRANSDUCTION; TROYER SYNDROME;

ANIMALS; AXONS; BONE MORPHOGENETIC PROTEINS; CARRIER PROTEINS; CELLS, CULTURED; CEREBRAL CORTEX; CHONDROCYTES; CYTOKINESIS; DISEASE MODELS, ANIMAL; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; FEMALE; FIBROBLASTS; GAIT; HUMANS; LIPID METABOLISM; LIPIDS; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; PHENOTYPE; PHOSPHOPROTEINS; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SMAD1 PROTEIN; SMAD5 PROTEIN; SPASTIC PARAPLEGIA, HEREDITARY;

EID: 84865082850     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds191     Document Type: Article

References (61)

1. Salinas, S., Proukakis, C., Crosby, A. and Warner, T.T. (2008) Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms. Lancet Neurol., 7, 1127-1138.
2. Blackstone, C., O'Kane, C.J. and Reid, E. (2011) Hereditary spastic paraplegias: membrane traffic and the motor pathway. Nat. Rev. Neurosci., 12, 31-42.
3. Harding, A.E. (1983) Classification of the hereditary ataxias and paraplegias. Lancet, 1, 1151-1155.
4. Fink, J.K. (2006) Hereditary spastic paraplegia. Curr. Neurol. Neurosci. Rep., 6, 65-76.
5. Soderblom, C. and Blackstone, C. (2006) Traffic accidents: molecular genetic insights into the pathogenesis of the hereditary spastic paraplegias. Pharmacol. Ther., 109, 42-56.
6. Dion, P.A., Daoud, H. and Rouleau, G.A. (2009) Genetics of motor neuron disorders: new insights into pathogenic mechanisms. Nat. Rev. Genet., 10, 769-782.
7. Park, S.H. and Blackstone, C. (2010) Further assembly required: construction and dynamics of the endoplasmic reticulum network. EMBO Rep., 11, 515-521.
8. Renvoisé, B. and Blackstone, C. (2010) Emerging themes of ER organization in the development and maintenance of axons. Curr. Opin. Neurobiol., 20, 531-537.
9. Blackstone, C. (2012) Cellular pathways of hereditary spastic paraplegia. Annu. Rev. Neurosci., 35, 25-47.
10. Cross, H.E. and McKusick, V.A. (1967) The Troyer syndrome: a recessive form of spastic paraplegia with distal muscle wasting. Arch. Neurol., 16, 473-485.
11. Patel, H., Cross, H., Proukakis, C., Hershberger, R., Bork, P., Ciccarelli, F.D., Patton, M.A., McKusick, V.A. and Crosby, A.H. (2002) SPG20 is mutated in Troyer syndrome, an hereditary spastic paraplegia. Nat. Genet., 31, 347-348.
12. Proukakis, C., Cross, H., Patel, H., Patton, M.A., Valentine, A. and Crosby, A.H. (2004) Troyer syndrome revisited. A clinical and radiological study of a complicated hereditary spastic paraplegia. J. Neurol., 251, 1105-1110.
13. Bakowska, J.C., Wang, H., Xin, B., Sumner, C.J. and Blackstone, C. (2008) Lack of spartin protein in Troyer syndrome: a loss-of-function disease mechanism? Arch. Neurol., 65, 520-524.
14. Manzini, M.C., Rajab, A., Maynard, T.M., Mochida, G.H., Tan, W.-H., Nasir, R., Hill, R.S., Gleason, D., Al Saffar, M., Partlow, J.N. et al. (2010) Developmental and degenerative features in a complicated spastic paraplegia. Ann. Neurol., 67, 516-525.
15. Lu, J., Rashid, F. and Byrne, P.C. (2006) The hereditary spastic paraplegia protein spartin localises to mitochondria. J. Neurochem., 98, 1908-1919.
16. Robay, D., Patel, H., Simpson, M.A., Brown, N.A. and Crosby, A.H. (2006) Endogenous spartin, mutated in hereditary spastic paraplegia, has a complex subcellular localization suggesting diverse roles in neurons. Exp. Cell Res., 312, 2764-2777.
17. Bakowska, J.C., Jupille, H., Fatheddin, P., Puertollano, R. and Blackstone, C. (2007) Troyer syndrome protein spartin is mono-ubiquitinated and functions in EGF receptor trafficking. Mol. Biol. Cell., 18, 1683-1692.
18. Eastman, S.W., Yassaee, M. and Bieniasz, P.D. (2009) A role for ubiquitin ligases and Spartin/SPG20 in lipid droplet turnover. J. Cell Biol., 184, 881-894.
19. Edwards, T.L., Clowes, V.E., Tsang, H.T.H., Connell, J.W., Sanderson, C.M., Luzio, J.P. and Reid, E. (2009) Endogenous spartin (SPG20) is recruited to endosomes and lipid droplets and interacts with the ubiquitin E3 ligases AIP4 and AIP5. Biochem. J., 423, 31-39.
20. Milewska, M., McRedmond, J. and Byrne, P.C. (2009) Identification of novel spartin-interactors shows spartin is a multifunctional protein. J. Neurochem., 111, 1022-1030.
21. Renvoisé, B., Parker, R.L., Yang, D., Bakowska, J.C., Hurley, J.H. and Blackstone, C. (2010) SPG20 protein spartin is recruited to midbodies by ESCRT-III protein Ist1 and participates in cytokinesis. Mol. Biol. Cell., 21, 3293-3303.
22. Joshi, D.C. and Bakowska, J.C. (2011) SPG20 protein spartin associates with cardiolipin via its plant-related senescence domain and regulates mitochondrial Ca2+ homeostasis. PLoS One, 6, e19290.
23. Ciccarelli, F.D., Proukakis, C., Patel, H., Cross, H., Azam, S., Patton, M.A., Bork, P. and Crosby, A.H. (2003) The identification of a conserved domain in both spartin and spastin, mutated in hereditary spastic paraplegia. Genomics, 81, 437-441.
24. Hooper, C., Puttamadappa, S.S., Loring, Z., Shekhtman, A. and Bakowska, J.C. (2010) Spartin activates atrophin-1-interacting protein 4 (AIP4) E3 ubiquitin ligase and promotes ubiquitination of adipophilin on lipid droplets. BMC Biol., 8, 72.
25. Hurley, J.H. and Hanson, P.I. (2010) Membrane budding and scission by the ESCRT machinery: it's all in the neck. Nat. Rev. Mol. Cell Biol., 11, 556-566.
26. Rotin, D. and Kumar, S. (2009) Physiological functions of the HECT family of ubiquitin ligases. Nat. Rev. Mol. Cell Biol., 10, 398-409.
27. Alberts, P. and Rotin, D. (2010) Regulation of lipid droplet turnover by ubiquitin ligases. BMC Biol., 8, 94.
28. Tsang, H.T.H., Edwards, T.L., Wang, X., Connell, J.W., Davies, R.J., Durrington, H.J., O'Kane, C.J., Luzio, J.P. and Reid, E. (2009) The hereditary spastic paraplegia proteins NIPA1, spastin and spartin are inhibitors of mammalian BMP signalling. Hum. Mol. Genet., 18, 3805-3821.
29. Wang, X., Shaw, W.R., Tsang, H.T.H., Reid, E. and O'Kane, C.J. (2007) Drosophila spichthyin inhibits BMP signaling and regulates synaptic growth and axonal microtubules. Nat. Neurosci., 10, 177-185.
30. O'Connor-Giles, K.M., Ho, L.L. and Ganetsky, B. (2008) Nervous wreck interacts with thickveins and the endocytic machinery to attenuate retrograde BMP signaling during synaptic growth. Neuron, 58, 507-518.
31. Bayat, V., Jaiswal, M. and Bellen, H.J. (2011) The BMP signaling pathway at the Drosophila neuromuscular junction and its links to neurodegenerative diseases. Curr. Opin. Neurobiol., 21, 182-188.
32. Charron, F. and Tessier-Lavigne, M. (2007) The Hedgehog, TGF-b/BMP, and Wnt families of morphogens in axon guidance. Adv. Exp. Med. Biol., 621, 116-133.
33. Zhu, P.-P., Soderblom, C., Tao-Cheng, J.-H., Stadler, J. and Blackstone, C. (2006) SPG3A protein atlastin-1 is enriched in growth cones and promotes axon elongation during neuronal development. Hum. Mol. Genet., 15, 1343-1353.
34. Solowska, J.M., Morfini, G., Falnikar, A., Himes, B.T., Brady, S.T., Huang, D. and Baas, P.W. (2008) Quantitative and functional analyses of spastin in the nervous system: implications for hereditary spastic paraplegia. J. Neurosci., 28, 2147-2157.
35. Raino, E., Martignoni, M., Cartelli, D., Crippa, F., Toldo, I., Siciliano, G., Di Bella, D., Taroni, F., Bassi, M.T., Cappelletti, G. and Rugarli, E. (2009) Pleitropic effects of spastin on neurite growth depending on expression levels. J. Neurochem., 108, 1277-1288.
36. Soderblom, C., Stadler, J., Jupille, H., Blackstone, C., Shupliakov, O. and Hanna, M.C. (2010) Targeted disruption of the Mast syndrome gene SPG21 in mice impairs hind limb function and alters axon branching in cultured cortical neurons. Neurogenetics, 11, 369-378.
37. Yang, D., Rismanchi, N., Renvoisé, B., Lippincott-Schwartz, J., Blackstone, C. and Hurley, J.H. (2008) Structural basis for midbody targeting of spastin by the ESCRT-III protein CHMP1B. Nat. Struct. Mol. Biol., 15, 1278-1286.
38. Lind, G.E., Raiborg, C., Danielsen, S.A., Rognum, T.O., Thiis-Evensen, E., Hoff, G., Nesbakken, A., Stenmark, H. and Lothe, R.A. (2011) SPG20, a novel biomarker for early detection of colorectal cancer, encodes a regulator of cytokinesis. Oncogene, 30, 3967-3978.
39. Bakowska, J.C., Jenkins, R., Pendleton, J. and Blackstone, C. (2005) The Troyer syndrome (SPG20) protein spartin interacts with Eps15. Biochem. Biophys. Res. Commun., 334, 1042-1048.
40. Simpson, M.A., Cross, H., Proukakis, C., Hershberger, R., Chatonnet, A., Patton, M.A. and Crosby, A.H. (2003) Maspardin is mutated in Mast syndrome, a complicated form of hereditary spastic paraplegia associated with dementia. Am. J. Hum. Genet., 73, 1147-1156.
41. Zeitlmann, L., Sirim, P., Kremmer, E. and Kolanus, W. (2001) Cloning of ACP33 as a novel intracellular ligand of CD4. J. Biol. Chem., 276, 9123-9132.
42. Polo, S. and Di Fiore, P.P. (2006) Endocytosis conducts the cell signaling orchestra. Cell, 124, 897-900.
43. Wegner, C.S., Rodahl, L.M.W. and Stenmark, H. (2011) ESCRT proteins and cell signalling. Traffic, 12, 1291-1297.
44. Rusten, T.E., Filimonenko, M., Rodahl, L.M., Stenmark, H. and Simonsen, A. (2008) ESCRTing autophagic clearance of aggregating proteins. Autophagy, 4, 233-236.
45. Bache, K.G., Stuffers, S., Malerød, L., Slagsvold, T., Raiborg, C., Lechardeur, D., Wälchli, S., Lukacs, G.L., Brech, A. and Stenmark, H. (2006) The ESCRT-III subunit hVps24 is required for degradation but not silencing of the epidermal growth factor receptor. Mol. Biol. Cell, 17, 2513-2523.
46. Urbanczyk, A. and Enz, R. (2011) Spartin recruits PKC-z via the PKC-z-interacting proteins ZIP1 and ZIP3 to lipid droplets. J. Neurochem., 118, 737-748.
47. Agarwal, A.K. and Garg, A. (2004) Seipin: a mysterious protein. Trends Mol. Med., 10, 440-444.
48. Ito, D. and Suzuki, N. (2009) Seipinopathy: a novel endoplasmic reticulum stress-associated disease. Brain, 132, 8-15.
49. Fei, W., Du, X. and Yang, H. (2011) Seipin, adipogenesis and lipid droplets. Trends Endocrinol. Metab., 22, 204-210.
50. Rainier, S., Bui, M., Mark, E., Thomas, D., Tokarz, D., Ming, L., Delaney, C., Richardson, R.J., Albers, J.W., Matsunami, N. et al. (2008) Neuropathy target esterase gene mutations cause motor neuron disease. Am. J. Hum. Genet., 82, 780-785.
51. Kienesberger, P.C., Lass, A., Preiss-Landl, K., Wolinski, H., Kohlwein, S.D., Zimmermann, R. and Zechner, R. (2008) Identification of an insulin-regulated lysophospholipase with homology to neuropathy target esterase. J. Biol. Chem., 283, 5908-5917.
52. Vose, S.C., Fujioka, K., Gulevich, A.G., Lin, A.Y., Holland, N.T. and Casida, J.E. (2008) Cellular function of neuropathy target esterase in lysophosphatidylcholine action. Toxicol. Appl. Pharmacol., 232, 376-383.
53. Read, D.J., Li, Y., Chao, M.V., Cavanagh, J.B. and Glynn, P. (2009) Neuropathy target esterase is required for adult vertebrate axon maintenance. J. Neurosci., 29, 11594-11600.
54. Moser, M., Li, Y., Vaupel, K., Kretzschmar, D., Kluge, R., Glynn, P. and Buettner, R. (2004) Placental failure and impaired vasculogenesis result in embryonic lethality for neuropathy target esterase-deficient mice. Mol. Cell. Biol., 24, 1667-1679.
55. Akassoglou, K., Malester, B., Xu, J., Tessarollo, L., Rosenbluth, J. and Chao, M.V. (2004) Brain-specific deletion of neuropathy target esterase/swisscheese results in neurodegeneration. Proc. Natl. Acad. Sci. USA, 101, 5075-5080.
56. Aszódi, A., Chan, D., Hunziker, E., Bateman, J.F. and Fässler, R. (1998) Collagen II is essential for the removal of the notochord and the formation of intervertebral discs. J. Cell Biol., 143, 1399-1412.
57. Zhu, P.-P., Patterson, A., Lavoie, B., Stadler, J., Shoeb, M., Patel, R. and Blackstone, C. (2003) Cellular localization, oligomerization, and membrane association of the hereditary spastic paraplegia 3A (SPG3A) protein atlastin. J. Biol. Chem., 278, 49063-49071.
58. Park, S.H., Zhu, P.-P., Parker, R.L. and Blackstone, C. (2010) Hereditary spastic paraplegia proteins REEP1, spastin, and atlastin-1 coordinate microtubule interations with the tubular ER network. J. Clin. Invest., 120, 1097-1110.
59. Burgess, R.W., Peterson, K.A., Johnson, M.J., Roix, J.J., Welsh, I.C. and O'Brien, T.P. (2004) Evidence for a conserved function in synapse formation reveals Phr1 as a candidate gene for respiratory failure in newborn mice. Mol. Cell. Biol., 24, 1096-1105.
60. Lepekhin, E.A., Walmod, P.S., Berezin, A., Berezin, V. and Bock, E. (2001) Evaluation of cell morphology. Methods Mol. Biol., 161, 85-100.
61. Spandl, J., White, D.J., Peychl, J. and Thiele, C. (2009) Live cell multicolor imaging of lipid droplets with a new dye, LD540. Traffic, 10, 1579-1584.